Package 50090-5163-2

{"route": ["ORAL"], "spl_id": "6f3ebf11-0131-4add-860d-3c3fe243d5ee", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["77b78d35-40f5-4713-8468-aa09a6c2925d"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0)", "package_ndc": "50090-5163-0", "marketing_start_date": "20200923"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1)", "package_ndc": "50090-5163-1", "marketing_start_date": "20200923"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2)", "package_ndc": "50090-5163-2", "marketing_start_date": "20200923"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "50090-5163_6f3ebf11-0131-4add-860d-3c3fe243d5ee", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5163", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20261231"}